Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A group has developed therapies that show promise for treating cancer and various other conditions.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Hair analysis can help screen for serious diseases like cancer and osteoporosis.

Hair fluorescence intensity can measure radiation exposure effectively.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Tigason improved hair growth in a boy with monilethrix without side effects.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

CS12192 effectively treats alopecia areata with better safety than current options.

New compounds may help treat heart disease by activating specific potassium channels.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A rare ovarian tumor in a 2-year-old girl was successfully removed, normalizing her hormone levels.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

CT scans can find serious prostate cancer even when PSA levels are low.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Placental mesenchymal stem cells and their conditioned medium significantly improve healing in local radiation injuries.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.